Atlantic Canada Opportunities Agency
Symbol of the Government of Canada



March 12, 2013 - Halifax, NS

The Honourable Alice Wong, Minister of State for Seniors, today marked the latest stage of progress for a Halifax-based company developing a device to significantly reduce the risks associated with undergoing general anesthesia. Minister Wong marked the achievement on behalf of the Honourable Gail Shea, Minister of National Revenue and Minister for the Atlantic Canada Opportunities Agency.

On May 12, 2012, the Honourable Peter MacKay, Minister of National Defence and Regional Minister for Nova Scotia, announced an investment of $1,245,617 in DMF Medical Incorporated. The investment was part of a total investment of more than $12 million made in six innovative research and development projects in Nova Scotia under the 2011 Competitive Round of the Atlantic Innovation Fund (AIF). The investment supports DMF Medical Incorporated’s work to finalize the product design of their ZeroSorb device, optimize its performance, conduct pre-clinical and clinical trials and regulatory approvals, and prepare for manufacturing and commercialization.

“As this Atlantic Innovation Fund project progresses, ZeroSorb is preparing to compete in the global marketplace,” said Minister Wong. “This type of accomplishment continues to build the reputation of Nova Scotia’s life sciences industry as a hot-spot for innovation and a great opportunity for investment.”

Today, one in four patients who undergo surgery involving general anesthesia suffers some form of cognitive impairment. Neurotoxins produced by the medical industry’s standard anesthesia devices contribute to this problem. These risks are significantly heightened for young people and seniors. With support though the AIF, DMF Medical Inc. has developed ZeroSorb, a CO2 removal device which uses membrane technology rather than absorbent chemicals to remove these toxins, creating safer delivery of anesthesia.

“We are pleased to be able to embark on this next stage of growth and development for the company,” said Dr. David Roach, on behalf of Dr. Michael Schmidt, Founder and Chief Medical Officer of DMF Medical Incorporated. “This technology has the potential to make a real impact in the field of medicine and in the lives of patients globally.”

Our Government remains focused on four priorities, as outlined by the Prime Minister, that Canadians care most about: their families, the safety of our streets and communities, their pride in being a citizen of this country, and of course, their personal financial security.


Minister Alice Wong today marked the progress of an ACOA Atlantic Innovation Fund project with DMF Medical Incorporated.

The company received $1,245,617 in May of 2012 and is moving forward with the commercialization of their ZeroSorb device which significantly reduces the risks associated with undergoing general anesthesia.

Minister Wong said this type of accomplishment is quickly positioning Nova Scotia’s life sciences industry as a hot-spot for innovation and a great opportunity for investment.



Christopher Brooks
Manager, Communications and Outreach
Atlantic Canada Opportunities Agency
902-426-4790/902-789-5184 (cell)

David Roach
Commercialization Manager
DMF Medical Incorporated
902- 209-0291